Spain – Vaccines – Adquisición vacuna frente al virus respiratorio sincitial (VRS)
Opportunity Score
Confidence: 40%
Complexity: medium
25 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
This tender by the Government of Castilla-La Mancha (Spain) seeks a supplier for an RSV vaccine for adults and high-risk populations. The tender is structured as a single lot (with multiple performance subdivisions) valued at €7,920,000, with a 13-month contract duration. The award is based on quality (60%) and price (40%). Submission is electronic in Spanish, deadline 10 July 2026 at 12:00 UTC. Note: structured data lists 8 lot entries but only the first contains complete details; the XML notice indicates one lot with five performance subdivisions. This inconsistency reduces data confidence.
Strengths
Documents available
Open procedure
Medium complexity
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Open procedure, electronic submission only
- Submission language: Spanish
- Deadline: 10 July 2026 at 12:00 UTC (14:00 CEST)
Buyer
Name
Secretaría General de la Consejería de Sanidad de la Junta de Comunidades de Castilla-La Mancha
Location
Toledo, ESP
Buyer profile
Identifier
20622420106002
Lots (3)
Supply of RSV vaccine for adults and high-risk groups. Performance in provinces: Albacete (ES421), Ciudad Real (ES422), Cuenca (ES423), Guadalajara (ES424), Toledo (ES425).
Lot for province ES422 (Ciudad Real).
Lot for province ES423 (Cuenca).
Procurement Details
Publication
10 Jun 2026
Deadline
10 Jul 2026, 12:00
Procedure
open
Contract
supplies
Duration
13 MONTH
Language
SPA
Publication #
400931-2026
Classification
Performance: Spain
Documents (2)
Opportunity Score
Confidence: 40%
Complexity: medium
25 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation